For investors using a methodical process to find leading companies with high growth, the CAN SLIM method, created by William O'Neil, is a foundational plan. It joins detailed examination of company finances with important chart-based signals to find stocks with solid profit growth, support from large investment firms, and leading traits, all while considering a positive overall market direction. This structured system helps select firms that are not only expanding but are also acknowledged and supported by the wider market.
A recent filter using this plan has identified Viemed Healthcare Inc (NASDAQ:VMD), a supplier of in-home breathing care and medical devices. The firm's latest financial and chart-based picture seems to match several central CAN SLIM rules, marking it as a subject for more examination by investors focused on growth.
Matching the CAN SLIM Rules
The CAN SLIM letters define particular, measurable standards. Viemed's present information indicates a notable match with many parts of this system:
- C - Current Quarterly Earnings & Sales: The plan requires solid recent progress. Viemed states a 40% rise in quarterly EPS compared to last year and a 25.5% gain in quarterly sales, easily passing the common minimum levels of 20-25% for growth speed.
- A - Annual Earnings Gains: To confirm durability beyond one quarter, CAN SLIM requires a record of expansion. Viemed displays a solid 3-year EPS compound annual growth rate (CAGR) of about 35%, significantly higher than the plan's standard goal.
- N - New Highs & Leadership: This rule focuses on a stock's market acceptance. In terms of price charts, VMD is changing hands near the top of its 52-week span and shows constructive long-term and short-term price movements, a signal of health. Its position in the enlarging home healthcare field connects with the "New Products/Services" element of searching for novel market areas.
- L - Leader or Laggard: Comparative performance is a main separator. With a ChartMill Comparative Performance score of 85.4, VMD is doing better than about 85% of all stocks, firmly putting it in the leading group the plan aims to find.
- I - Institutional Sponsorship: While some ownership by large firms is needed, a very high level can restrict possible future purchasing. Viemed's institutional ownership is at a moderate 66.8%, indicating potential for more institutional finding and funding.
- S - Supply, Demand & Financial Health: The firm holds a very small debt-to-equity figure of 0.08, showing a sound financial position with little borrowing, which is a good mark for financial condition and steadiness.
Financial and Chart-Based Overview
An inspection of Viemed's detailed reports gives background for these filter outcomes. The fundamental analysis report gives VMD a score of 6 out of 10, noting its very good earnings ability and financial condition. Main positives involve a good Return on Equity (ROE) of 10.55%, solid earnings margins compared to its sector, and a very sound Altman-Z score signaling minimal risk of failure. The report states the company is "displaying very good growth while it is priced at fair levels," but mentions that some reduction in margins has happened lately.
Regarding price charts, the technical analysis report gives a highest score of 10 out of 10. It affirms the constructive price movements across various periods and mentions the stock's major better performance compared to both the general market and its sector competitors over the last year. Presently, the stock is seen to be creating a possible bull flag shape, a pause after a large rise, which chart-based traders frequently monitor for signs of continued movement. The report also sees recent activity from big participants, as shown by trade volume study.
Market Setting and Closing Thoughts
The "M" in CAN SLIM represents Market Direction, a vital point that even the most sound single stock can face difficulty in a poor general market. At this time, the long-term movement for the S&P 500 stays constructive, while the short-term movement is without a clear direction. This varied-to-constructive setting is a needed factor for the plan, implying that the total market situation may not be a barrier for leading stocks such as VMD.
It is critical to see this filter outcome as a beginning for study, not a final endorsement. While Viemed Healthcare shows a picture that fits the growth and movement filters of the CAN SLIM plan, investors should perform their own complete examination. This involves reviewing the firm's competitive field, leadership plans, and any possible legal or sector-specific challenges.
For investors wanting to find other firms that presently pass comparable CAN SLIM-based filters, you can review the ready-made filter here.
Disclaimer: This article is for information only and is not investment guidance, a suggestion, or a proposal to purchase or sell any security. The information and study shown are from sources thought to be dependable, but their correctness is not assured. Investors should do their own separate study and talk with a registered financial consultant before making any investment choices.